WILMINGTON, Del. (AP)- A major drugmaker has accepted the state's offer of an $11 million grant to remain in Delaware.
Under the deal, Incyte Corp. will have to add 260 jobs in three years, and those jobs have to remain in Delaware until 2018.
The money comes from the Delaware Economic Development Office. DEDO director Alan Levin says Incyte was "being courted by Pennsylvania and New Jersey." He says the company offers jobs with an average salary of $140,000, and he wanted to keep those in Delaware.
Incyte chief financial officer Dave Hastings says the state has shown a "strong commitment" to the firm.